Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 603 37 970.2 |
96 | EP file number | EAKZ | 03 71 6092.6 |
86 | WO file number | WAKZ | PCT/US03/05043 |
97 | EP publication number | EPN | 1430157 |
87 | WO publication number | WPN | 2003070750 |
54 | Designation/title | TI | DURCH EINE STÖRUNG DER RNA VERMITTELTE INHIBIERUNG DER GENEXPRESSION DES HEPATITIS C VIRUS (HCV) MIT KURZER, STÖRENDER NUKLEINSÄURE (SHORT INTERFERING NUCLEIC ACID, SINA) |
51 | IPC main class | ICM (ICMV) | C07H 21/04 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07H 21/02 (2006.01), C12N 15/85 (2006.01), C12N 15/86 (2006.01), C12P 19/34 (2006.01), A61K 48/00 (2006.01) |
22 | DE application date | DAT | Feb 20, 2003 |
96 | EP application date | EAT | Feb 20, 2003 |
86 | WO application date | WAT | Feb 20, 2003 |
43 | Date of first publication | OT | Aug 28, 2003 |
| Date of publication of grant | PET | Aug 10, 2011 |
71/73 | Applicant/owner | INH | Sirna Therapeutics, Inc., Boulder, Col., US |
72 | Inventor | IN | BEIGELMAN, Leonid, Longmont, CO 80503, US; MORRISSEY, David, Boulder, CO 80301, US; MACEJAK, Dennis, Arvada, CO 80004, US; McSWIGGEN, James, Boulder, CO 80301, US |
74 | Representative | VTR | Abitz & Partner Patentanwälte mbB, 81925 München, DE |
| Address for service | | Abitz & Partner Patentanwälte mbB, 81628 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| WO PCT/US02/09187 Mar 26, 2002
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 440129 P Jan 15, 2003
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 409293 P Sep 9, 2002
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 358580 P Feb 20, 2002
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 406784 P Aug 29, 2002
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 386782 P Jun 6, 2002
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 363124 P Mar 11, 2002
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 408378 P Sep 5, 2002
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 401104 P Aug 5, 2002
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, SE, SI, SK, TR |
81 | Designated WO countries | WDS | LT, AL, LV, MK, RO |
| Published EP/WO documents | EPWOPN | Original document:
EP000001430157 Searchable text:
EP000001430157 Original document:
EP000001430157B1 Searchable text:
EP000001430157B1 Original document:
WO002003070750 Searchable text:
WO002003070750 |
43 | Date of first publication | EVT | Aug 28, 2003 |
| Date of the first transfer into DPMAregister | EREGT | May 26, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 26, 2018 (Show all update days)(Hide all update days)- Oct 26, 2018; Nov 15, 2017; Nov 27, 2014; Oct 18, 2014; Jul 16, 2014; Jul 5, 2014; Jun 17, 2014; Mar 8, 2014; Mar 20, 2013; Mar 12, 2013; Jan 26, 2013; Sep 6, 2012; Jul 13, 2012; Jun 26, 2012; Jun 20, 2012; May 15, 2012; May 1, 2012; Mar 31, 2012; Mar 6, 2012; Feb 25, 2012; Dec 1, 2011; Oct 26, 2011; Oct 20, 2011; Oct 12, 2011; Oct 8, 2011; Sep 24, 2011; Aug 30, 2011; Aug 12, 2011
- Historical data not available for this/these date(s)
- May 26, 2011
- Date of the first transfer into DPMAregister
|